EP1989319A4 - VARIANTS OF COMPLEMENTARY REGULATOR GENES AS FORECAST FOR AGE-RELATED MACULAR GENERATION - Google Patents

VARIANTS OF COMPLEMENTARY REGULATOR GENES AS FORECAST FOR AGE-RELATED MACULAR GENERATION

Info

Publication number
EP1989319A4
EP1989319A4 EP07750527A EP07750527A EP1989319A4 EP 1989319 A4 EP1989319 A4 EP 1989319A4 EP 07750527 A EP07750527 A EP 07750527A EP 07750527 A EP07750527 A EP 07750527A EP 1989319 A4 EP1989319 A4 EP 1989319A4
Authority
EP
European Patent Office
Prior art keywords
macular degeneration
related macular
gene variants
regulation gene
complement regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07750527A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1989319A2 (en
Inventor
Rando L Allikmets
Gregory S Hageman
Michael C Dean
Albert M Gold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Columbia University in the City of New York
National Institutes of Health NIH
Original Assignee
University of Iowa Research Foundation UIRF
Columbia University in the City of New York
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF, Columbia University in the City of New York, National Institutes of Health NIH filed Critical University of Iowa Research Foundation UIRF
Publication of EP1989319A2 publication Critical patent/EP1989319A2/en
Publication of EP1989319A4 publication Critical patent/EP1989319A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP07750527A 2006-02-13 2007-02-13 VARIANTS OF COMPLEMENTARY REGULATOR GENES AS FORECAST FOR AGE-RELATED MACULAR GENERATION Withdrawn EP1989319A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77298906P 2006-02-13 2006-02-13
PCT/US2007/003696 WO2007095185A2 (en) 2006-02-13 2007-02-13 Variants in complement regulatory genes predict age-related macular degeneration

Publications (2)

Publication Number Publication Date
EP1989319A2 EP1989319A2 (en) 2008-11-12
EP1989319A4 true EP1989319A4 (en) 2009-11-11

Family

ID=38372062

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07750527A Withdrawn EP1989319A4 (en) 2006-02-13 2007-02-13 VARIANTS OF COMPLEMENTARY REGULATOR GENES AS FORECAST FOR AGE-RELATED MACULAR GENERATION

Country Status (8)

Country Link
EP (1) EP1989319A4 (enExample)
JP (1) JP5290772B2 (enExample)
CN (1) CN101421409A (enExample)
AU (1) AU2007215218B2 (enExample)
CA (1) CA2638916A1 (enExample)
IL (1) IL193396A (enExample)
NZ (1) NZ570431A (enExample)
WO (1) WO2007095185A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012683B2 (en) 2006-02-13 2011-09-06 University Of Iowa Research Foundation Variants in complement regulatory genes predict age-related macular degeneration
WO2010127176A2 (en) * 2009-04-29 2010-11-04 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing detecting age-related macular degeneration
EP2963128A1 (en) 2009-07-10 2016-01-06 The Regents of the University of Michigan Compositions and methods for diagnosing and treating macular degeneration
US20110104154A1 (en) * 2009-10-30 2011-05-05 Alcon Research, Ltd. Single nucleotide polymorphisms and genes associated with age-related macular degeneration
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
CN102707068B (zh) * 2012-05-31 2015-03-18 北京大学 补体h因子用作甲基苯丙胺成瘾患者的基因表达产物中的应用
JP6387391B2 (ja) 2013-03-14 2018-09-05 ノバルティス アーゲー 眼科疾患の処置に有用な補体因子Ｂ阻害剤としての２−（１Ｈ−インドール−４−イルメチル）−３Ｈ−イミダゾ［４，５−ｂ］ピリジン−６−カルボニトリル誘導体
EP3089963A1 (en) 2013-10-30 2016-11-09 Novartis AG 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
EP3102701A1 (en) * 2014-02-07 2016-12-14 Novartis AG Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
WO2016100745A2 (en) * 2014-12-19 2016-06-23 Children's Hospital Medical Center Methods and compositions related to transplant-associated thrombotic microangiopathy
CN109082460B (zh) * 2018-09-27 2021-07-13 领航基因科技（杭州）有限公司 应用于snp分型的非竞争性探针设计方法、检测方法及应用
KR102414152B1 (ko) * 2020-08-20 2022-06-29 (주)지놈오피니언 연령 관련 황반변성 진단용 바이오마커 및 이의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062716A2 (en) * 2004-11-18 2006-06-15 Yale University Methods and compositions for treating ocular disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575586B2 (en) 1983-09-02 1988-08-04 Syngene, Inc. Oligonucleotide synthesis employing primer with oxidzable substituents in system
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
DE69503126T2 (de) 1994-05-05 1998-11-12 Beckman Instruments Inc Repetitive oligonukleotide matrix
US5985567A (en) 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
US6013789A (en) 1998-02-20 2000-01-11 Beckman Coulter, Inc. Covalent attachment of biomolecules to derivatized polypropylene supports

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062716A2 (en) * 2004-11-18 2006-06-15 Yale University Methods and compositions for treating ocular disorders

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
"Homo sapiens bead probe urn: LSID:sanger.hapmap.org:Assay:1730462:1 for variation rs4151667", Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/probe/?term=pr501784&report=fullreport> *
"Homo sapiens bead probe urn:LSID:sanger.hapmap.org:Assay:1727808:1 for variation rs641153", Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/probe/503071?report=fullreport> *
"Homo sapiens SSO probe urn:lsid:perlegen.hapmap.org:Assay:25175.4056446:1 for variation rs547154", Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/probe/3131349> *
CHARBEL ISSA P ET AL: "The complement system and its possible role in the pathogenesis of age-related macular degeneration (AMD)", OPHTHALMOLOGE 2005 GERMANY, vol. 102, no. 11, 2005, pages 1036 - 1042, XP002452750, ISSN: 0941-293X *
DATABASE HAPMAP PROJECT HOMPAGE [online] XP002452762, retrieved from HTTP://WWW.HAPMAP.ORG/DOWNLOADS/ASSAY-DESIGN_PROTOCOLS.HTML *
DATABASE PROBE [online] 16 September 2005 (2005-09-16), XP002452757, retrieved from NCBI Database accession no. Pr503071 *
DATABASE PROBE [online] 16 September 2005 (2005-09-16), XP002452758, retrieved from NCBI Database accession no. Pr501784 *
DATABASE PROBE [online] 24 January 2006 (2006-01-24), XP002452761, retrieved from NCBI Database accession no. Pr003249825 *
DATABASE PROBE [online] 25 January 2006 (2006-01-25), XP002452759, retrieved from NCBI Database accession no. Pr003131349 *
DATABASE PROBE [online] 5 October 2005 (2005-10-05), XP002452760, retrieved from NCBI Database accession no. Pr001347746 *
DATABASE SNP [online] 3 December 2002 (2002-12-03), XP002550606, retrieved from NCBI Database accession no. rs641153 *
DATABASE SNP [online] 3 December 2002 (2002-12-03), XP002550607, retrieved from NCBI Database accession no. rs4151667 *
DATABASE SNP [online] 3 December 2002 (2002-12-03), XP002550609, retrieved from NCBI Database accession no. rs1048709 *
DATABASE SNP [online] 3 September 2003 (2003-09-03), XP002550605, retrieved from NCBI Database accession no. rs9332739 *
DATABASE SNP [online] 3 September 2003 (2003-09-03), XP002550608, retrieved from NCBI Database accession no. rs547154 *
FAN BAO JIAN ET AL: "Molecular diagnostics of genetic eye diseases", CLINICAL BIOCHEMISTRY, vol. 39, no. 3, January 2006 (2006-01-01), pages 231 - 239, XP002452749, ISSN: 0009-9120 *
GOLD BERT ET AL: "Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration", NATURE GENETICS, vol. 38, no. 4, April 2006 (2006-04-01), pages 458 - 462, XP002452747, ISSN: 1061-4036 *
GUNDERSON KEVIN L ET AL: "A genome-wide scalable SNP genotyping assay using microarray technology", NATURE GENETICS, vol. 37, no. 5, May 2005 (2005-05-01), pages 549 - 554, XP002452745, ISSN: 1061-4036 *
HAGEMAN GREGORY S ET AL: "A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 102, no. 20, May 2005 (2005-05-01), pages 7227 - 7232, XP002391909, ISSN: 0027-8424 *
MALLER JULIAN ET AL: "Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration", NATURE GENETICS, vol. 38, no. 9, September 2006 (2006-09-01), pages 1055 - 1059, XP002452748, ISSN: 1061-4036 *
MATSUZAKI HAJIME ET AL: "GENOTYPING OVER 100,000 SNPS ON A PAIR OF OLIGONUCLEOTIDE ARRAYS", NATURE METHODS, vol. 1, no. 2, 1 November 2004 (2004-11-01), NATURE PUBLISHING GROUP, GB, pages 109 - 111, XP009082656, ISSN: 1548-7091, DOI: 10.1038/NMETH718 *
See also references of WO2007095185A2 *
ZIPFEL P F ET AL: "Complement and diseases: Defective alternative pathway control results in kidney and eye diseases", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 43, no. 1-2, 1 January 2006 (2006-01-01), pages 97 - 106, XP025037099, ISSN: 0161-5890, [retrieved on 20060101] *

Also Published As

Publication number Publication date
WO2007095185A2 (en) 2007-08-23
IL193396A0 (en) 2009-05-04
JP2009526524A (ja) 2009-07-23
IL193396A (en) 2013-03-24
WO2007095185A3 (en) 2008-09-25
EP1989319A2 (en) 2008-11-12
CN101421409A (zh) 2009-04-29
JP5290772B2 (ja) 2013-09-18
AU2007215218B2 (en) 2013-09-19
NZ570431A (en) 2011-12-22
AU2007215218A1 (en) 2007-08-23
CA2638916A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
EP1989319A4 (en) VARIANTS OF COMPLEMENTARY REGULATOR GENES AS FORECAST FOR AGE-RELATED MACULAR GENERATION
GB2476188B (en) Evaluating genetic disorders
IL196624A0 (en) Method for identifying novel genes
IL186542A0 (en) Improved methods controlling gene expression
EP2024311A4 (en) INTEGRATED PROCESS FOR THE PRODUCTION OF AROMATICS
DK2540843T3 (da) Genetiske polymorfismer ved aldersbetinget makulær degeneration
GB0512707D0 (en) Gene expression technique
ZA200809908B (en) Methods for weed control
GB0718942D0 (en) Method for detecting small oligonucleotides
EP1806393A4 (en) MICROREACTOR FOR GENETIC TEST
DE602007001537D1 (de) Modulares System zum Schnee-reisen für Schuhwerk
IL190795A0 (en) Genes associated with macular degeneration
PT2816118T (pt) Métodos para administração de genes
GB0601179D0 (en) Therapies for psychotic disorders
EP1861511A4 (en) GENETIC VARIANTS INCREASE THE RISK OF AGE-RELATED MACULAR GENERATION
GB0623551D0 (en) Refringement extenders for HCFL 22
DK1841859T3 (da) Alleler fra mqo-genet fra coryneforme bakterier
GB0716947D0 (en) Genetic analysis
GB0525523D0 (en) Genetic process
EP2002840A4 (en) METHOD FOR THE TREATMENT OF ONCOLOGICAL ILLNESSES
GB0604893D0 (en) Vector Replacement Method
PL2092081T3 (pl) Sposoby i zastosowania obejmujące genetyczne nieprawidłowości w chromosomie 12
GB0610574D0 (en) Novel schizophrenia associated genes
GB0812661D0 (en) Genetic tests 11
GB0605999D0 (en) Predicting Gene Expression Levels

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080826

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF IOWA RESEARCH FOUNDATION

Owner name: NATIONAL INSTITUTES OF HEALTH, DHHS

Owner name: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF IOWA RESEARCH FOUNDATION

Owner name: NATIONAL INSTITUTES OF HEALTH

Owner name: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF

A4 Supplementary search report drawn up and despatched

Effective date: 20091008

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20091002BHEP

17Q First examination report despatched

Effective date: 20100127

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NATIONAL INSTITUTES OF HEALTH

Owner name: UNIVERSITY OF IOWA RESEARCH FOUNDATION

Owner name: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160308

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160719